文献速递肿瘤 PET/CT神经核医学

1型神经纤维瘤病中良性、非典型与恶性外周神经鞘瘤的鉴别——正电子发射计算机断层显像与扩散加权磁共振成像的个体内比较

Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 - intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imaging.
PubMed 文献 · EJNMMI Res · 2024-12-27

这项前瞻性单中心研究在34例1型神经纤维瘤病患者中个体内比较了F-18-FDG-PET/CT与多b值DW-MRI对66个外周神经鞘瘤(39个良性、11个非典型、16个恶性)的鉴别诊断效能,结果显示SUVmax与ADC参数均具有良好诊断准确性,但DW-MRI未能证明非劣效于PET/CT。

要点

  • SUVmax的AUC为94.0%,ADCmean/min/dark的AUC分别为91.6%/90.1%/92.5%。
  • 三种ADC参数与SUVmax的AUC差值置信区间下限分别为-12.9%/-14.5%/-11.6%,均未达非劣效。
  • 两种影像技术的评分者间信度均优秀,Krippendorff's alpha均>0.94。

核心结论

  • PET/CT衍生的SUVmax和MRI衍生的ADC均能灵敏且无创地鉴别良性与(前)恶性外周神经鞘瘤。
  • 然而,在这项前瞻性单中心研究中,DW-MRI不能被认为非劣效于F-18-FDG-PET/CT。

研究设计与样本

  • 前瞻性单中心研究,采用非劣效性设计,个体内比较F-18-FDG-PET/CT与扩散加权磁共振成像。
  • 纳入34例1型神经纤维瘤病患者(18例男性;年龄30±11岁),在3T下行F-18-FDG-PET/CT和多b值DW-MRI(11个b值,0-800 s/mm²)。
  • 评估66个病灶,对应39个良性外周神经鞘瘤、11个非典型神经纤维瘤和16个恶性外周神经鞘瘤。
  • 两名放射科医师独立评估最大标准化摄取值(SUVmax)、平均和最小表观扩散系数(ADCmean/min)以及每个病灶最低信号强度区域的ADC(ADCdark)。
  • 诊断参考标准为随访≥24个月(良性外周神经鞘瘤)或组织病理学评估(恶性外周神经鞘瘤+非典型神经纤维瘤)。

主要发现

  • SUVmax和ADC参数均表现出良好的诊断准确性:AUC SUVmax为94.0%,AUC ADCmean/min/dark分别为91.6%/90.1%/92.5%。
  • 三种ADC参数与SUVmax的AUC差值置信区间下限分别为-12.9%/-14.5%/-11.6%,均未达到非劣效界值-10%,故未证明非劣效性。
  • 两种影像技术的评分者间信度均优秀,Krippendorff's alpha均>0.94。

关键数值与推荐

  • 非劣效性界值为-10%。
  • ADCmean/min/dark与SUVmax的AUC差值置信区间下限分别为-12.9%/-14.5%/-11.6%。
  • SUVmax的AUC为94.0%;ADCmean/min/dark的AUC分别为91.6%/90.1%/92.5%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To intraindividually compare the diagnostic performance of positron emission computed tomography (F-18-FDG-PET/CT) and diffusion-weighted magnetic resonance imaging (DW-MRI) in a non-inferiority design for the discrimination of peripheral nerve sheath tumours as benign (BPNST), atypical (ANF), or malignant (MPNST) in patients with neurofibromatosis type 1 (NF1). RESULTS: In this prospective single-centre study, thirty-four NF1 patients (18 male; 30 ± 11 years) underwent F-18-FDG-PET/CT and multi-b-value DW-MRI (11 b-values 0 - 800 s/mm²) at 3T. Sixty-six lesions corresponding to 39 BPNST, 11 ANF, and 16 MPNST were evaluated. Two radiologists independently assessed the maximum standardized uptake value (SUVmax) and mean and minimum apparent diffusion coefficient (ADCmean/min) as well as the ADC in areas of lowest signal intensity in each lesion (ADCdark). The AUCs of DW-MRI and F-18-FDG-PET/CT were compared to determine whether the ADC is non-inferior to SUVmax (non-inferiority margin equal to -10%). Follow-up of ≥ 24 months (BPNST) or histopathological evaluation (MPNST + ANF) served as diagnostic reference standard. Both SUVmax and ADC parameters demonstrated good diagnostic accuracy (AUCSUVmax 94.0%; AUCADCmean/min/dark 91.6% / 90.1% / 92.5%). However, non-inferiority could not be demonstrated for any of the three ADC parameters (lower limits of the confidence intervals of the difference between the AUC of ADCmean/min/dark and SUVmax -12.9% / -14.5% / -11.6%). Inter-rater reliability was excellent for both imaging techniques (Krippendorff's alpha all > 0.94). CONCLUSIONS: Both PET/CT-derived SUVmax and MRI-derived ADC allow sensitive and non-invasive differentiation of benign and (pre)-malignant peripheral nerve sheath tumours. Nevertheless, DW-MRI cannot be considered as non-inferior to F-18-FDG-PET/CT in this prospective single-centre study.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Ristow I, Apostolova I, Kaul MG, et al. Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 - intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imaging. EJNMMI Res. 2024. PMID: 39729173. doi:10.1186/s13550-024-01189-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。